Skip to main content
PMC home page
Journal of Urban Health : Bulletin of the New York Academy of Medicine logoLink to Journal of Urban Health : Bulletin of the New York Academy of Medicine
. 2005 Sep;82(3):479–487. doi: 10.1093/jurban/jti095

A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City

Benny J Kottiri 1,✉, Samuel R Friedman 2, Gary L Euler 3, Peter L Flom 2, Milagros Sandoval 2, Alan Neaigus 4, Don C Des Jarlais 5, Jonathan M Zenilman 6
PMCID: PMC3456058  PMID: 16033931

Abstract

We conducted a community-based study of the prevalence and correlates of hepatitis B virus (HBV) infection and immunization among young adults in a “drug supermarket” neighborhood in New York City. Four hundred eighty-nine young adults ages 18–24 years were recruited from Bushwick, Brooklyn through multistage household probability sampling (n=332) and targeted sampling (n=157), interviewed, and tested for three hepatitis B markers (HBsAg, anti-HBc, and anti-HBs). Serological evidence of HBV infection was found in 8.0% (6.0% in the household sample and 12.1% in the targeted sample) and of hepatitis B immunization in 19.6% (22.6% in the household sample and 13.4% in the targeted sample). HBV infection was higher among young adults who either used crack or injected drugs and among those who traded sex for money or drugs. Having Medicaid was significantly associated with lower odds of infection in the household sample and higher odds of immunization in the targeted sample. Although adolescent hepatitis B immunization has been a public health priority in the United States since 1995, nearly three-quarters of young adults in this community did not have serological evidence of being either exposed or immunized. Whereas subsequent younger generations benefited from universal childhood hepatitis B immunization, this particular cohort of young adults who live in communities like Bushwick presents a unique group for prevention intervention.

Keywords: Drug use, Hepatitis B infection, Hepatitis B vaccination, Youth

Full Text

The Full Text of this article is available as a PDF (89.7 KB).

Footnotes

The opinions expressed herein are those of the authors and not of USAID or other organizations to which the authors belong.

References

  • 1.Hepatitis B Surveillance Report 57. Atlanta, GA: U.S. Department of Health and Human Services; 2000. [Google Scholar]
  • 2.McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14–18. doi: 10.2105/ajph.89.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.William IT, Goldstein ST, Tufa J, et al. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J. 2003;22:157–163. doi: 10.1097/00006454-200302000-00013. [DOI] [PubMed] [Google Scholar]
  • 4.Centers for Disease Control and Prevention Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR Morb Mortal Wkly Rep. 1991;40:1–19. [PubMed] [Google Scholar]
  • 5.Centers for Disease Control and Prevention Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Morb Mortal Wkly Rep. 1996;45(RR-13):1–6. [PubMed] [Google Scholar]
  • 6.Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976–94: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis. 1988;178:954–959. doi: 10.1086/515696. [DOI] [PubMed] [Google Scholar]
  • 7.Centers for Disease Control and Prevention. Disease burden from viral hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/resource/PDFs/disease_burden2004.pdf. Accessed March 30, 2005.
  • 8.Yusuf HR, Coronado VG, Averhoff FA, et al. Progress in coverage with hepatitis B vaccine among US children, 1994–1997. Am J Public Health. 1999;89:1684–1689. doi: 10.2105/AJPH.89.11.1684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mast EE, Williams IT, Alter MJ, Margolis HS. Hepatitis B vaccination of adolescent and adult high-risk groups in the United States. Vaccine. 1998;16:S27–S29. doi: 10.1016/S0264-410X(98)00288-6. [DOI] [PubMed] [Google Scholar]
  • 10.Zimet GD, Kee R, Winston Y, et al. Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sex Transm Dis. 2001;28:678–680. doi: 10.1097/00007435-200111000-00011. [DOI] [PubMed] [Google Scholar]
  • 11.Rich JD, Ching CG, Lally MA, et al. A review of the case for hepatitis B vaccination of high-risk adults. Am J Med. 2003;114:316–318. doi: 10.1016/S0002-9343(02)01560-7. [DOI] [PubMed] [Google Scholar]
  • 12.Dufor A, Remis RS, Alary M, et al. Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada. Sex Transm Dis. 1999;26:317–324. doi: 10.1097/00007435-199907000-00002. [DOI] [PubMed] [Google Scholar]
  • 13.Moore-Caldwell SY, Werner MJ, Powell L, Greene JW. Hepatitis B vaccination in adolescents: knowledge, perceived risk, and compliance. J Adolesc Health. 1997;20:294–299. doi: 10.1016/S1054-139X(96)00276-5. [DOI] [PubMed] [Google Scholar]
  • 14.Sharfstein J, Wise PH. Inadequate hepatitis B vaccination of adolescents, and adults at an urban community health center. J Natl Med Assoc. 1997;89:86–92. [PMC free article] [PubMed] [Google Scholar]
  • 15.Jain N, Yusuf H, Wortley PM, et al. Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Interview Survey, 2000. Fam Med. 2004;36:480–486. [PubMed] [Google Scholar]
  • 16.Jarlais DC, Fisher DG, Newman JC, et al. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs. on-site vaccination at a syringe exchange program. Am J Public Health. 2001;91:1791–1792. doi: 10.2105/ajph.91.11.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lum PJ, Ochoa KC, Hahn JA, et al. Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO study. Am J Public Health. 2003;93:919–923. doi: 10.2105/ajph.93.6.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Mak R, Traen M, Claeyssens M, et al. Hepatitis B vaccination for sex workers: do outreach programmes perform better. Sex Transm Infect. 2003;79:157–159. doi: 10.1136/sti.79.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am. 1994;23:437–455. [PubMed] [Google Scholar]
  • 20.Hernandez MT, Klausner JD, McFarland W, et al. Hepatitis B prevalence in young women living in low-income areas: the population-based San Francisco Bay area’s Young Women’s Survey. Sex Transm Dis. 2000;27:539–544. doi: 10.1097/00007435-200010000-00007. [DOI] [PubMed] [Google Scholar]
  • 21.Friedman SR, Curtis R, Jose B, et al. Sex, drugs, and infections among youth: parenterally and sexually transmitted diseases in a high-risk neighborhood. Sex Transm Dis. 1997;24:322–326. doi: 10.1097/00007435-199707000-00003. [DOI] [PubMed] [Google Scholar]
  • 22.Friedman SR, Curtis R, Neaigus A, Jose B, Jarlais DC. Social Networks, Drug Injectors’ Lives, and HIV/AIDS. New York, NY: Kluwer/Plenum; 1999. [Google Scholar]
  • 23.Watters JK, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36:416–430. [Google Scholar]
  • 24.Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44:174–199. [Google Scholar]
  • 25.Flom PL, Friedman SR, Kottiri BJ, et al. Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood. Sex Transm Dis. 2001;28:598–607. doi: 10.1097/00007435-200110000-00006. [DOI] [PubMed] [Google Scholar]
  • 26.Agresti A, Coull BA. Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat. 1998;52:119–126. doi: 10.2307/2685469. [DOI] [Google Scholar]
  • 27.Gandhi RT, Wurcel A, Lee H, et al. Isolated antibody to hepatitis B core antigen in human immunodeficiency virus type-1-infected individuals. Clin Infect Dis. 2003;36:1602–1605. doi: 10.1086/375084. [DOI] [PubMed] [Google Scholar]
  • 28.National Health and Nutrition Examination Survey III, 1988-94. Hyattsville, MD: Centers for Disease Control and Prevention; 1997. [Google Scholar]
  • 29.Friedman SR, Flom P, Kottiri BJ, et al. Prevalence and correlates of anal sex with men among young adult women in an inner city minority neighborhood. AIDS. 2001;15:2057–2060. doi: 10.1097/00002030-200110190-00025. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Urban Health : Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES